- 专利标题： HEPATITIS C VIRUS NS3/4A PROTEASE INHIBITORS
-
申请号： US17607886申请日： 2020-06-05
-
公开(公告)号： US20220227806A1公开(公告)日： 2022-07-21
- 发明人: Celia A. Schiffer , Akbar Ali , Jacqueto Zephyr , Ashley N. Matthew , Nageswara R. Desaboini
- 申请人： University of Massachusetts
- 申请人地址： US MA Boston
- 专利权人： University of Massachusetts
- 当前专利权人： University of Massachusetts
- 当前专利权人地址： US MA Boston
- 国际申请： PCT/US20/36302 WO 20200605
- 主分类号： C07K5/083
- IPC分类号： C07K5/083 ; C07K5/107
摘要：
The invention provides novel classes of HCV therapeutics that are orally available, safe and effective HCV NS3/4A protease inhibitors and are less susceptible to drug resistance than existing therapeutics. The invention also relates to pharmaceutical composition of these compounds and methods of preparation and use thereof.
信息查询
